First-In-Human Results on the Biodistribution, Pharmacokinetics, and Dosimetry of [¹⁷⁷Lu]Lu-DOTA.SA.FAPi and [¹⁷⁷Lu]Lu-DOTAGA.(SA.FAPi)₂

• Päätekijät: Sanjana Ballal (Tekijä), Madhav Prasad Yadav (Tekijä), Euy Sung Moon (Tekijä), Vasko S Kramer (Tekijä), Frank Roesch (Tekijä), Samta Kumari (Tekijä), Chandrasekhar Bal (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: MDPI AG, 2021-11-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Recently, great interest has been gained regarding fibroblast activation protein (FAP) as an excellent target for theranostics. Several FAP inhibitor molecules such as [⁶⁸Ga]Ga-labelled FAPI-02, 04, 46, and DOTA.SA.FAPi have been introduced and are highly promising molecular t...